Navigation Links
NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award
Date:3/23/2009

M. Frederick Hawthorne, Ph.D. Honored for Distinguished Service in the Field of Chemistry

EMERYVILLE, Calif., March 23 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY) today announced that world-renowned scientist M. Frederick Hawthorne, Ph.D., a member of the Company's Scientific Advisory Board will be the recipient of the 2009 Priestley Medal, the highest honor awarded by the American Chemical Society (ACS). Dr. Hawthorne, who is co-director of the International Institute for Nano and Molecular Medicine at the University of Missouri-Columbia, will be presented this award for distinguished service in the field of chemistry at the Spring ACS National Meeting to be held this week in Salt Lake City, Utah.

"Dr. Hawthorne is a world-renowned scientist who has brought his impeccable credentials and expertise to NovaBay," said Dr. Ron Najafi, chairman and chief executive officer of NovaBay. "We are extremely proud and honored to have such a distinguished leader of the chemical community on our Scientific Advisory Board. We congratulate him on receiving the prestigious 2009 Priestley Medal."

Dr. Hawthorne has contributed to the development of NovaBay's Aganocide(R) class of antimicrobial molecules specifically designed by NovaBay to mimic the body's natural defense against infection. These compounds may deliver the same or better level of antimicrobial activity as is currently reached by common antibiotics without contributing to the growing rise in bacterial resistance. The Aganocide compounds have shown in preclinical trials to date to be highly effective against bacteria, viruses and fungi. They have also been demonstrated to be effective against bacteria in biofilm, for which most antibiotics are rendered ineffective. These compounds have a potentially broad therapeutic index providing a high degree of potency, good tolerability, together with dosing versatility an
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
2. NovaBay announces third quarter 2007 financial results
3. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., , Association Discusses Key Provisions ...lth Care Reform ,, ST. CHARLES, Ill., Nov. 21 ...f Representatives passing the landmark Affordable ...enate moving key health reform legislation forward...ion,s broken health care system. Today, AARP host...
(Date:11/21/2009)... NH based medical credent...irst in its industry to form a partnerhsip with Am... U.S. This partnership will help to transform qua... (Vocus) November 21, 2009 -- ISG ...as announced a new agreement with Amerinet Inc., a...
(Date:11/21/2009)... HAPPYneuron,s most popul...e on the iPhone and iPod Touch. , ...09 -- HAPPYneuron,s most popular and addictive gam...iPod Touch. Split Words is designed to help banish...he SplitWords iPhone brain game challenges the b...
(Date:11/21/2009)... New Haven Dental Group m...n, D.D.S of Branford, CT. , ...al Group, comprised of partners Dr. David Gibson, ...ph Forrester has just merged their growing practic...ckman., , ,When Dr. Pickman decided he wanted to r...
(Date:11/20/2009)..., , Pioneering Neurologist Closer to Unders..., Nov. 20 Dr. Jeremy Sc...l School and neurologist at the Massachusetts Gene...presented his laboratory,s research on the new fie... the MINDlink Foundation. ,, Dr. Schmahmann is ...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:New Haven Dental Group Expands Their Vision 2Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...s the name given to a condition characterized by a...ms. Although it remains one of the toughest // con...table. The condition affects women more than men a...or some antibiotics. “We're not exactly certain wh...
...hologist at the University of Alberta people who d...ildren compared to people who wear them. // In add...opulation Research Lab states that young attractiv...ch 862 caretaker-children combinations were furtiv...
...Y.S. Rajasekhara Reddy announced the launch of the...common man//. The insurance, which has a highly su...ers, agricultural labourers and artisans. The Chie...es, who are currently living below the poverty lin...
...se who suffer from severe chronic obstructive pulm...hat breathing a special gas mixture may help in dr...h individuals. Patients revealed that after breath...l of Respiratory and Critical Care Medicine, publi...
...y researchers has highlighted that most of the US ...s required// for follow up tests done to evaluate ...the 436 men who underwent vasectomy at the Clevela...tus. The results of the study can be cited in the ...
...e routinely employed to remove abnormal cells in t...plications//, reveals a new study conducted by res...oes not hold good for laser ablation, highlights t...y small. If abnormal cells are detected in the ini...
Other Medicine News:Health News:Get that wedding ring on if you want to be branded a responsible parent! 2Health News:COPD Patients portray improved exercise performance after breathing a Special Gas 2Health News:Men Unaware of Fertility Status After Vasectomy 2Health News:Cervical Procedures Increase Risk Of Pregnancy Complications 2
(Date:11/20/2009).... 20 Smith & Nephew ...o announce the signing of a technology development...ense that may lead to the creation of a fracture f...ment of the limbs of soldiers who sustain battlefi...d Research Projects Agency (DARPA), the central re...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
(Date:11/19/2009)...Nov. 19 Ligon Discovery, Inc., whi...nology to find drugs against high-value targets, t...ncing led by incTANK Ventures. The company will us...mpaign that will screen over 100 high-value diseas...entures General Partner Christian Bailey joins the...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3MHPA Leading Association Representing Medicaid Health Plans Issues Statement on Proposed California SCHIP Elimination 47534 1MHPA Leading Association Representing Medicaid Health Plans Issues Statement on Proposed California SCHIP Elimination 47534 2Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 1Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 2Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 3Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 4Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 5Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 1Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 2Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 3Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 4Pixantrone Significantly Increases Complete Remissions Overall Response Rates Frequency of Durable Remissions and Progression Free Survival in Patie 12396 5
...l Incorporated,(Nasdaq: VICL ) today announced th...rial of the company,s Vaxfectin(TM)-formulated pla...uble-blind, placebo-controlled trial will,evaluate...o 60 healthy,volunteers age 18 to 45 at two U.S. c...emic influenza vaccine and,demonstrated its effect...
...ies Set To Begin By Early 2008, WOODRIDGE, Ill., ...sdaq: ADLS ) today announced that the United,Stat...Orphan Drug,Designation to its oncology product, A...lanoma. Melanoma is estimated to be the sixth most...ited States and accounts for,about 4% of all skin ...
Other Medicine Technology:Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza 2Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza 3Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza 4Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 2Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 3Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 4
Salmonella Typhi Antigen - Rapid Test
IntraStent DoubleStrut
hCG Urine Cassette 5mm - Rapid Test
hCG Combo Urine/Serum - Rapid Test
Medicine Products: